ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $33,576,000 | +378.1% | 361,267 | +206.3% | 0.02% | +360.0% |
Q3 2021 | $7,023,000 | +56.4% | 117,932 | +79.1% | 0.01% | +25.0% |
Q2 2021 | $4,490,000 | +6.7% | 65,841 | +8.5% | 0.00% | 0.0% |
Q1 2021 | $4,210,000 | -20.4% | 60,671 | -11.8% | 0.00% | -20.0% |
Q4 2020 | $5,287,000 | -43.9% | 68,809 | -45.4% | 0.01% | -54.5% |
Q3 2020 | $9,431,000 | +23.9% | 126,097 | +4.3% | 0.01% | +22.2% |
Q2 2020 | $7,613,000 | +97.3% | 120,939 | +31.6% | 0.01% | +80.0% |
Q1 2020 | $3,859,000 | -14.3% | 91,873 | -7.3% | 0.01% | +25.0% |
Q4 2019 | $4,501,000 | +10.0% | 99,086 | +10.8% | 0.00% | 0.0% |
Q3 2019 | $4,092,000 | -32.9% | 89,443 | -14.0% | 0.00% | -33.3% |
Q2 2019 | $6,101,000 | +34.5% | 104,063 | +2.8% | 0.01% | +50.0% |
Q1 2019 | $4,536,000 | +78.0% | 101,187 | +54.6% | 0.00% | +33.3% |
Q4 2018 | $2,549,000 | +237.6% | 65,456 | +298.9% | 0.00% | +200.0% |
Q3 2018 | $755,000 | +19.7% | 16,409 | +13.4% | 0.00% | 0.0% |
Q2 2018 | $631,000 | -84.7% | 14,475 | -86.2% | 0.00% | -75.0% |
Q1 2018 | $4,129,000 | – | 104,538 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |